...
首页> 外文期刊>Cancer radiotherapie: journal de la Soci閠?fran鏰ise de radiotherapie oncologique >Radiosurgery of single brain metastasis without combined total cerebral irradiation. Results of a consecutive series of 12 cases
【24h】

Radiosurgery of single brain metastasis without combined total cerebral irradiation. Results of a consecutive series of 12 cases

机译:没有合并全脑照射的单脑转移放疗。连续12例结果

获取原文
获取原文并翻译 | 示例

摘要

PURPOSE: To evaluate the usefulness of radiosurgery without whole brain irradiation for a solitary brain metastasis. PATIENTS AND METHODS: Between December 1994 and November 1996, 12 patients were treated for a single brain metastasis by radiosurgery alone. Median age was 53, and 10 patients had a Karnofsky performance status above 70. Half the patients had active extracranial disease at the time of radiosurgery. Stereotactic radiosurgery delivered a single dose of 20 Gy (specified at the isocenter with a 70% isodose reference curve). Evaluation of results was performed according to local control, survival, evolution of performance status, as well as evolution of neurologic symptoms. RESULTS: No patient had immediate toxicity. One month later, ten patients showed improvement in their neurologic impairments, and none had progression of the cerebral lesion according to CT scan evaluation (diminution for seven patients, and stabilization for five). Local control rate was 58%, and median time to failure was 4 months. The overall median survival time was 10 months. Three patients were alive, with good performance status, and six died following cerebral progression. CONCLUSION: These poor results in terms of local control are in favor of supplementary whole brain irradiation, except for particular cases.
机译:目的:评估没有全脑照射的放射外科手术对孤立性脑转移的有用性。患者与方法:1994年12月至1996年11月,仅通过放射外科手术治疗了12例单发脑转移患者。中位年龄为53岁,其中10名患者的Karnofsky行为状态超过70岁。一半的患者在接受放射外科手术时患有活动性颅外疾病。立体定向放射外科手术单剂量为20 Gy(在等中心点指定,等剂量参考曲线为70%)。根据局部控制,生存率,表现状态的演变以及神经系统症状的演变对结果进行评估。结果:没有患者立即发生毒性反应。一个月后,根据CT扫描评估结果,有10名患者的神经功能障碍得到了改善,没有一个脑部病变的进展(缩小了7例,稳定了5例)。局部控制率为58%,平均失败时间为4个月。总体中位生存时间为10个月。 3名患者还活着,并且状态良好,有6名患者因脑部疾病死亡。结论:在局部控制方面这些较差的结果有利于补充全脑照射,特殊情况除外。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号